AAAAAA

   
Results: 1-8 |
Results: 8
ADVERSE EVENTS AND DISCOMFORT IN STUDIES IN HEALTHY-SUBJECTS - THE VOLUNTEERS PERSPECTIVE - A SURVEY CONDUCTED BY THE GERMAN-ASSOCIATION-FOR-APPLIED-HUMAN-PHARMACOLOGY
Authors: HERMANN R HEGERMAHN D MAHLER M SEIBERTGRAFE M KLIPPING C BREITHAUPTGROGLER K DEMEY C
Citation: R. Hermann et al., ADVERSE EVENTS AND DISCOMFORT IN STUDIES IN HEALTHY-SUBJECTS - THE VOLUNTEERS PERSPECTIVE - A SURVEY CONDUCTED BY THE GERMAN-ASSOCIATION-FOR-APPLIED-HUMAN-PHARMACOLOGY, European Journal of Clinical Pharmacology, 53(3-4), 1997, pp. 207-214
INHIBITION OF FIBRINOGEN BINDING TO GLYCOPROTEIN IIB IIIA AS A NOVEL BIOASSAY FOR THE DETERMINATION OF FIBRINOGEN RECEPTOR ANTAGONISTIC PLASMA EQUIVALENTS/
Authors: JABLONKA B BROCKMEIER D JUST M MAAS J SCHMIDT D SEIBERTGRAFE M STILZ U
Citation: B. Jablonka et al., INHIBITION OF FIBRINOGEN BINDING TO GLYCOPROTEIN IIB IIIA AS A NOVEL BIOASSAY FOR THE DETERMINATION OF FIBRINOGEN RECEPTOR ANTAGONISTIC PLASMA EQUIVALENTS/, Naunyn-Schmiedeberg's archives of pharmacology, 356(4), 1997, pp. 17-17
SITE-DEPENDENT SMALL-INTESTINAL ABSORPTION OF THE ACE-INHIBITOR RAMIPRIL
Authors: GRAMATTE T BROCKMEIER D HERBIG U SEIBERTGRAFE M
Citation: T. Gramatte et al., SITE-DEPENDENT SMALL-INTESTINAL ABSORPTION OF THE ACE-INHIBITOR RAMIPRIL, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 58-58
PHARMACOKINETICS, PHARMACODYNAMICS AND BIOAVAILABILITY OF THE ACE-INHIBITOR RAMIPRIL
Authors: VANGRIENSVEN JMT SCHOEMAKER RC COHEN AF LUUS HG SEIBERTGRAFE M ROTHIG HJ
Citation: Jmt. Vangriensven et al., PHARMACOKINETICS, PHARMACODYNAMICS AND BIOAVAILABILITY OF THE ACE-INHIBITOR RAMIPRIL, European Journal of Clinical Pharmacology, 47(6), 1995, pp. 513-518
DEALING WITH ADVERSE EVENTS IN PHASE-I TR IALS
Authors: HEGERMAHN D MAHLER M HERMANN R NOWAK H WEBER W SEIBERTGRAFE M
Citation: D. Hegermahn et al., DEALING WITH ADVERSE EVENTS IN PHASE-I TR IALS, Arzneimittel-Forschung, 45-1(3), 1995, pp. 331-336
LACK OF INTERACTION BETWEEN RAMIPRIL AND SIMVASTATIN
Authors: MEYER BH SCHOLTZ HE MULLER FO LUUS HG DELAREY N SEIBERTGRAFE M ECKERT HG METZGER H
Citation: Bh. Meyer et al., LACK OF INTERACTION BETWEEN RAMIPRIL AND SIMVASTATIN, European Journal of Clinical Pharmacology, 47(4), 1994, pp. 373-375
DIFFERENTIAL-EFFECTS OF THE NOVEL NO-DONATING DRUG PIRSIDOMINE AND ISOSORBIDE DINITRATE ON THE VENOUS VASCULAR BED
Authors: DEMEY C BREITHAUPT K SEIBERTGRAFE M BELZ GG
Citation: C. Demey et al., DIFFERENTIAL-EFFECTS OF THE NOVEL NO-DONATING DRUG PIRSIDOMINE AND ISOSORBIDE DINITRATE ON THE VENOUS VASCULAR BED, European Journal of Clinical Pharmacology, 46(4), 1994, pp. 295-299
THE PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS OF RAMIPRIL WITHPROPRANOLOL
Authors: VANGRIENSVEN JMT SEIBERTGRAFE M SCHOEMAKER HC FROLICH M COHEN AF
Citation: Jmt. Vangriensven et al., THE PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS OF RAMIPRIL WITHPROPRANOLOL, European Journal of Clinical Pharmacology, 45(3), 1993, pp. 255-260
Risultati: 1-8 |